Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
A Case of Covid-19 Infection in a Kidney Transplant Recipient After Receiving the Single Dose of Covid-19 Vaccination Publisher



Rahbar M1 ; Sharifi Y2 ; Kazem Aghamir SM1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Urology Research Center, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran

Source: Annals of Medicine and Surgery Published:2022


Abstract

Introduction and importance: As immunocompromised individuals, kidney transplant recipients (KTR) were more prone to severe and prolonged COVID-19 infection. Case presentation: A 52-year-old man with a history of two kidney transplants for polycystic kidney disease (PKD) was hospitalized due to COVID-19 illness after receiving the first dose of COVID-19 vaccination with Sputnik V. After being admitted to the hospital, the patient was given Remdesivir and oxygen therapy. Clinical discussion: We reported a COVID-19 infection after the first dose of Sputnik V vaccination in an immunocompromised patient who did not follow the protocols after vaccination. Regardless of vaccination, he had been infected, but the vaccination saved him from severe infection despite his comorbidity. Conclusion: To summarise, infection with COVID-19 should be considered after vaccinations, particularly the first dose, in immunocompromised patients such as KTR, and protocols for these patients should be strictly followed. It is worth mentioning that even a full dose of vaccination does not provide full protection from infection to anyone, including KTR. © 2022 The Authors
Related Docs
View other Related Docs
1. Seroconversion Following the First, Second, and Third Dose of Sars-Cov-2 Vaccines in Immunocompromised Population: A Systematic Review and Meta-Analysis, Virology Journal (2022)
2. A Narrative Review on Adverse Drug Reactions of Covid-19 Treatments on the Kidney, Open Medicine (Poland) (2024)
3. Covid-19 Vaccine Boosters: The Good, the Bad, and the Ugly, Vaccines (2021)
4. Immunogenicity of Covid-19 Mrna Vaccines in Immunocompromised Patients: A Systematic Review and Meta-Analysis, European Journal of Medical Research (2022)
5. Covid-19 Vaccinations: The Unknowns, Challenges, and Hopes, Journal of Medical Virology (2022)
6. Hospital-Acquired Infections in A Tertiary Hospital in Iran Before and During the Covid-19 Pandemic, Wiener Medizinische Wochenschrift (2022)
7. The Syndemic Theory, the Covid-19 Pandemic, and the Epidemics of Non-Communicable Diseases (Ncds), Medical Journal of the Islamic Republic of Iran (2022)
8. Acute Ischemic Stroke and Vaccine-Induced Immune Thrombotic Thrombocytopenia Post Covid-19 Vaccination; a Systematic Review, Journal of the Neurological Sciences (2022)
Experts (# of related papers)
View all Related Experts
Nima Rezaei (8)
Seyed Mohammad Kazem Aghamir Mohammad Ali (4)
Other Related Docs
9. Sars-Cov-2: Current Trends in Emerging Variants, Pathogenesis, Immune Responses, Potential Therapeutic, and Vaccine Development Strategies, International Immunopharmacology (2021)
10. The Prognostic Significance of Insulin Resistance in Covid-19: A Review, Journal of Diabetes and Metabolic Disorders (2024)
11. Effectiveness of Covid-19 Vaccines Against Delta (B.1.617.2) Variant: A Systematic Review and Meta-Analysis of Clinical Studies, Vaccines (2022)
12. Sars-Cov-2 Mrna-Vaccine Candidate; Corenapcin®, Induces Robust Humoral and Cellular Immunity in Mice and Non-Human Primates, npj Vaccines (2022)
13. The Tsunami of Covid-19 Infection Among Kidney Transplant Recipients: A Single-Center Study From Iran, Journal of Epidemiology and Global Health (2021)
14. Sudden Sensorineural Hearing Loss After Receiving an Inactivated Viral Vaccine, Sinopharm: Two-Case Report, SAGE Open Medical Case Reports (2023)
15. The Impact of Covid-19 Pandemic on Genitourinary Cancers Stage and Grade, Clinical Genitourinary Cancer (2023)
16. Association of Sars-Cov-2 Vaccination or Infection With Bell Palsy: A Systematic Review and Meta-Analysis, JAMA Otolaryngology - Head and Neck Surgery (2023)
17. Short-Term Sars-Cov-2 Re-Infection Rate in Vaccinated Health Workers Based on Received Vaccines: A Cross-Sectional Study, Current Respiratory Medicine Reviews (2023)
18. Covid-19 Vaccines Mix-And-Match: The Concept, the Efficacy and the Doubts, Journal of Medical Virology (2022)
19. The Effect of Covid-19 Mrna Vaccines Against Postvaccination Laboratory-Confirmed Sars-Cov-2 Infection, Symptomatic Covid-19 Infection, Hospitalization, and Mortality Rate: A Systematic Review and Meta-Analysis, Expert Review of Vaccines (2022)
20. Covid-19 Vaccines Cost-Effectiveness Analysis: A Scenario for Iran, Vaccines (2022)
21. The Clinical Impact of Mrna Therapeutics in the Treatment of Cancers, Infections, Genetic Disorders, and Autoimmune Diseases, Heliyon (2024)
22. Safety and Immunogenicity of a Recombinant Receptor-Binding Domain-Based Protein Subunit Vaccine (Noora Vaccine™) Against Covid-19 in Adults: A Randomized, Double-Blind, Placebo-Controlled, Phase 1 Trial, Journal of Medical Virology (2023)
23. Diagnostic Performance of a Novel Antigen-Capture Elisa for the Detection of Sars-Cov-2, Analytical Biochemistry (2023)
24. Acceptance or Rejection of the Covid-19 Vaccine: A Study on Iranian People’S Opinions Toward the Covid-19 Vaccine, Vaccines (2022)
25. Risk of Flare or Relapse in Patients With Immune-Mediated Diseases Following Sars-Cov-2 Vaccination: A Systematic Review and Meta-Analysis, European Journal of Medical Research (2024)
26. Cutaneous Adverse Reactions Following Covid-19 Vaccinations: A Systematic Review and Meta-Analysis, Journal of Cosmetic Dermatology (2022)
27. The Quest for a Better Fight: How Can Nanomaterials Address the Current Therapeutic and Diagnostic Obstacles in the Fight Against Covid-19?, Journal of Drug Delivery Science and Technology (2022)
28. The Effectiveness of Covid-19 Vaccines in Reducing the Incidence, Hospitalization, and Mortality From Covid-19: A Systematic Review and Meta-Analysis, Frontiers in Public Health (2022)
29. Breakthrough Sars-Cov-2 Infections After Vaccination: A Critical Review, Human Vaccines and Immunotherapeutics (2022)
30. Short-Term Safety of Covaxin, Sinopharm, Sputnik V, and Astrazeneca Covid-19 Vaccines Among Iranian Healthcare Workers: A Cross-Sectional Study, Archives of Clinical Infectious Diseases (2024)
31. Importance of the Covid-19 Vaccine Booster Dose in Protection and Immunity, Vaccines (2022)
32. Immunologic Response, Efficacy, and Safety of Vaccines Against Covid-19 Infection in Healthy and Immunosuppressed Children and Adolescents Aged 2 – 21 Years Old: A Systematic Review and Meta-Analysis, Journal of Clinical Virology (2022)
33. Covid-19 Infection Risk Following Elective Arthroplasty and Surgical Complications in Covid-19-Vaccinated Patients: A Multicenter Comparative Cohort Study, Arthroplasty Today (2022)
34. The Chimera of S1 and N Proteins of Sars-Cov-2: Can It Be a Potential Vaccine Candidate for Covid-19?, Expert Review of Vaccines (2022)
35. Recent Developments in Sars-Cov-2 Vaccines: A Systematic Review of the Current Studies, Reviews in Medical Virology (2023)
36. Safety and Efficacy of Rcp Recombinant Spike Protein Covid-19 Vaccine Compared to Sinopharm Bbibp: A Phase Iii, Non-Inferiority Trial, Heliyon (2024)
37. Vlp-Based Covid-19 Vaccines: An Adaptable Technology Against the Threat of New Variants, Vaccines (2021)
38. Characterization of Stability, Safety and Immunogenicity of the Mrna Lipid Nanoparticle Vaccine Iribovax® Against Covid-19 in Nonhuman Primates, Journal of Controlled Release (2023)
39. The Effect of Covid 19 Vaccination on Kidney Recipients, Transplant Immunology (2022)
40. Sars-Cov-2 Antibody Response After Bbibp-Corv (Sinopharm) Vaccination in Cancer Patients: A Case-Control Study, Frontiers in Medicine (2023)
41. Aging & Covid-19 Susceptibility, Disease Severity, and Clinical Outcomes: The Role of Entangled Risk Factors, Experimental Gerontology (2021)
42. Safety and Immunogenicity of Corenapcin, a Sars-Cov-2 Mrna Vaccine, As a Fourth Heterologous Booster in Healthy Iranian Adults: A Double-Blind, Randomized, Placebo-Controlled, Phase 1 Clinical Trial With a Six-Month Follow-Up, International Immunopharmacology (2024)